Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.annonc.2020.07.010 http://scihub22266oqcxt.onion/10.1016/j.annonc.2020.07.010 32745693!7836806!32745693     free     free     free Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Oncol 2020 ; 31 (10): 1320-1335 Nephropedia Template TP {{tp|p=32745693|t=2020. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus |pdf=|usr=}}{{32745693}} gab.com Text Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus JO: Ann Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32745693 #FOAvip We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic. Twit Text FOAVip Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus ????Ann Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32745693 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32745693 #FOAvip English Wikipedia <ref>{{Cite pmid|32745693}}</ref> Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus #MMPMID32745693 Curigliano G; Banerjee S; Cervantes A; Garassino MC; Garrido P; Girard N; Haanen J; Jordan K; Lordick F; Machiels JP; Michielin O; Peters S; Tabernero J; Douillard JY; Pentheroudakis G Ann Oncol 2020[Oct]; 31 (10): 1320-1335 PMID32745693show ga We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic. |*Betacoronavirus[MESH] |*Consensus[MESH] |*Coronavirus Infections/epidemiology/immunology/therapy[MESH] |*Medical Oncology/methods/standards[MESH] |*Neoplasms/epidemiology/immunology/therapy[MESH] |*Pneumonia, Viral/epidemiology/immunology/therapy[MESH] |*Societies, Medical/standards[MESH] |COVID-19[MESH] |Disease Management[MESH] |Europe/epidemiology[MESH] |Granulocyte Colony-Stimulating Factor/pharmacology/therapeutic use[MESH] |Humans[MESH] |Pandemics/prevention & control[MESH] |Real-Time Polymerase Chain Reaction/methods/standards[MESH] |SARS-CoV-2[MESH] |T-Lymphocytes, Cytotoxic/drug effects/immunology[MESH]Managing cancer patients during the COVID-19 pandemic: an ESMO multidi(epmc).pdf DeepDyve Pubget Overpricing